Figure 2.SUCRA plot of CDK 4/6 efficacy ranking for progression free survival vs. overall survival.
Figure 2 — Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis | Aging
